News

Filter

Current filters:

GenmabResearch

1 to 9 of 10 results

Genmab transfers its ofatumumab collaboration from GSK to Novartis

Genmab transfers its ofatumumab collaboration from GSK to Novartis

03-11-2014

Danish biotech company Genmab has entered into an agreement with UK pharma major GlaxoSmithKline and…

DenmarkGenmabGSKNovartisOfatumumab InjectionOncologyPharmaceuticalResearch

Genmab gets latest milestone in daratumumab Janssen collaboration

Genmab gets latest milestone in daratumumab Janssen collaboration

24-10-2014

Danish biotech company Genmab has reached the fourth milestone in its daratumumab collaboration with…

daratumumabDenmarkGenmabJanssenOncologyPharmaceuticalResearch

Seattle Genetics and Genmab sign new antibody-drug conjugate deal

Seattle Genetics and Genmab sign new antibody-drug conjugate deal

10-09-2014

Biotech companies Seattle Genetics of the USA and Denmark’s Genmab have entered into an additional…

BiotechnologyGenmabHuMax-TACLicensingOncologyResearchSeattle Genetics

GSK and Genmab announce positive interim results for ofatumumab Phase III

GSK and Genmab announce positive interim results for ofatumumab Phase III

01-08-2014

UK Pharma major GlaxoSmithKline and Danish biotechnology company Genmab have said that an interim analysis…

Chronic lymphocytic leukemiaDenmarkGenmabGSKOfatumumabOfatumumab InjectionOncologyPharmaceuticalRafael AmadoResearchUK

GSK and Genmab reveal disappointing Ph III data with ofatumumab + chemo in B-cell lymphoma

20-05-2014

UK Pharma major GlaxoSmithKline and Denmark’s Genmab revealed yesterday that the Phase III ORCHARRD…

GenmabGlaxoSmithKlineOfatumumab InjectionOncologyPharmaceuticalResearch

Genmab and ADC Thera link for antibody drug conjugate combining HuMax-TAC and PBD warhead

18-06-2013

Denmark's Genmab (OMX: GEN) and Switzerland-based ADC Therapeutics have entered an agreement to develop…

ADC TherapeuticsBiotechnologyGenmabHuMax-TACLicensingOncologyResearch

Research briefs: Lilly's Forteo; Genmab/GSK's Arzerra; AstraZeneca's Symbicort

30-05-2013

US drug major Eli Lilly (NYSE: LLY) has reported new data demonstrating that Forteo (teriparatide) significantly…

Anti-Arthritics/RheumaticsArzerraAstraZenecaEli LillyForteoGenmabGlaxoSmithKlineOncologyPharmaceuticalResearchRespiratory and PulmonarySymbicort

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top